检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:卢曦[1] 张淑香[1] 原红艳[1] 覃煜[1] 李旭征[1] 刘平[1]
机构地区:[1]武警医学院附属医院耳鼻咽喉科,天津300162
出 处:《武警医学院学报》2010年第10期761-763,F0002,共4页Acta Academiae Medicinae CPAPF
基 金:武警医学院科研基金项目(WY2008-19)
摘 要:【目的】探讨FADD在喉癌组织中的表达情况及其与临床的关系。【方法】应用免疫组织化学方法检测30例喉鳞状细胞癌组织、20例喉乳头状瘤组织、20例癌旁正常粘膜组织中FADD的表达情况。【结果】(1)FADD在喉鳞状细胞癌组、喉乳头状瘤组及癌旁正常粘膜组中的阳性表达率分别为76.7%、90.0%、95.0%,阳性表达率总体有统计学意义(P<0.05)。(2)FADD的阳性表达率在喉癌I^II期的阳性表达率为95.2%,III^IV期为50.0%,有统计学意义(P<0.05);在高分化癌组织中的阳性表达率为94.4%,中低分化癌组织中的阳性表达率为25.0%,有统计学意义(P<0.05)。FADD阳性表达率与患者性别、年龄、不同临床分型及是否伴有淋巴结转移均无关,无统计学意义(P>0.05)。【结论】FADD在喉癌的发生发展中起着重要的作用,癌组织中FADD的检测对临床预后的判断有一定的指导意义。【Objective】To explore the clinical significance of FADD in laryngeal squamous carcinoma.【Methods】 The expression of FADD were detected by immunohistochemiscal(IHC) method in 30 cases of larynx squamous cell carcinoma(LSCC),20 cases of papilloma of larynx and 20 cases of normal adjacent mucosa.【Results】(1) The positive expression rate of FADD in LSCC group,papilloma of larynx group and normal adjacent mucosa group were 76.7%,90.0%,95.0% respectively,the positive expression rate have statistical significance in total(P0.05).(2) The positive expression rates of FADD were related to cinical stage and with the degree of pathological differentiation,that.In stage I-II group of LSCC was 95.2% and stage of III-IV was 50.0%,with statistical significance(P0.05).In LSCC of high differentiation was 94.4%,higher than middle-poorly differentiated(25.0%),with statistical significance(P0.05).But no relation to sexuality,age,clinical classification and the lymph node metastasis.There were have no statistical significance(P0.05).【Conclusions】 FADD plays an important role in the occurrence and development of carcinoma of larynx.Determination expression rate of FADD may provide guidance for clinical prognosis.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117